Superior mesenteric venous thrombosis: Endovascular management and outcomes

Table 2 Treatment options and patient outcomes (n = 24)

Measure	Value1
Endovascular modality2
Thrombectomy	12 (50.0)
Thrombolysis	10 (41.7)
Stent placement	9 (37.5)
TIPS	6 (25.0)
Balloon angioplasty	4 (16.7)
Technical success outcome3	18 (75.0)
Complete	11 (61.1)
Partial	7 (38.9)
Clinical outcome
Resolution	11 (45.8)
Partial improvement	9 (37.5)
Not changed	3 (12.5)
Got worse	1 (4.2)
Clavien-Dindo classification4
Grade I	4 (16.7)
Grade II	5 (20.8)
Grade III	1 (4.2)
Grade IV	0 (0.0)
Grade V	1 (4.2)
Intestinal resection	1 (4.2)
In-hospital time, d	12 (1-68)
Readmission	1 (4.2)
Follow-up duration, mo	23 (1-145)

¹Values reported as n (%) or median (range).

²Of 54.2% (n = 13) patients had more than 1 modality.

³Of 6 patients did not establish a primary flow.

⁴Of 13 patients did not develop minor or major complications.

TIPS: Transjugular intrahepatic portosystemic shunt.